Predicting Outcomes in Posttransplant Diabetes Mellitus Via microRNA
NCT ID: NCT07055984
Last Updated: 2025-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
130 participants
OBSERVATIONAL
2025-04-28
2029-04-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Additionally, the investigators are evaluating how traditional risk factors-such as age, immunosuppressive therapy, obesity, and infections like CMV-interact with these microRNA markers.
The ultimate goal of this research is to identify early indicators of blood sugar issues, enabling timely interventions to improve health outcomes and personalize patient care after kidney transplantation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Define Predictors for Posttransplant Diabetes Mellitus Study
NCT06440330
Microcirculation of Patients With Kidney Transplant
NCT02874781
Biomarkers of Kidney Function in Transplant Medicine
NCT05538234
MiRNA in Kidney Transplantation: Association With Kidney Graft Function and Disease Process
NCT04413916
Development and Validation of a Multidimensional Score to Predict Long-term Kidney Transplant Outcomes
NCT03474003
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients after primary kidney transplantation without type 1 or type 2 diabetes melltus
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Absence of pre-existing type 1 or type 2 diabetes mellitus.
* Willingness to provide informed consent and comply with study procedures.
Exclusion Criteria
* Previous organ transplantation.
* Severe comorbidities that could confound the assessment of PTDM (e.g., pancreatic disease).
* Inability to provide informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Martin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matej Vnucak
Study coordinator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Transplant-nephorlogy department
Martin, , Slovakia
University hospital Martin
Martin, , Slovakia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
University hospital Martin
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.